218 related articles for article (PubMed ID: 15088307)
1. No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study.
Kendall SA; Schaadt ML; Graff LB; Wittrup I; Malmskov H; Krogsgaard K; Bartels EM; Bliddal H; Danneskiold-Samsøe B
J Rheumatol; 2004 Apr; 31(4):783-4. PubMed ID: 15088307
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Distler O; Eich W; Dokoupilova E; Dvorak Z; Fleck M; Gaubitz M; Hechler M; Jansen JP; Krause A; Bendszus M; Pache L; Reiter R; Müller-Ladner U
Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
Holman AJ; Myers RR
Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
[TBL] [Abstract][Full Text] [Related]
4. The course of pain in Bell's palsy: treatment with prednisolone and valacyclovir.
Berg T; Axelsson S; Engström M; Stjernquist-Desatnik A; Pitkäranta A; Kanerva M; Jonsson L
Otol Neurotol; 2009 Sep; 30(6):842-6. PubMed ID: 19503012
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
6. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
[TBL] [Abstract][Full Text] [Related]
8. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
9. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
Handsfield HH; Warren T; Werner M; Phillips JA
Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
[TBL] [Abstract][Full Text] [Related]
10. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.
Baker D; Eisen D
Cutis; 2003 Mar; 71(3):239-42. PubMed ID: 12661753
[TBL] [Abstract][Full Text] [Related]
11. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
[TBL] [Abstract][Full Text] [Related]
12. Valacyclovir in the treatment of facial herpes simplex virus infection.
Laiskonis A; Thune T; Neldam S; Hiltunen-Back E
J Infect Dis; 2002 Oct; 186 Suppl 1():S66-70. PubMed ID: 12353189
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
Warren T; Harris J; Brennan CA
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
[TBL] [Abstract][Full Text] [Related]
15. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
16. Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir.
Quan D; Hammack BN; Kittelson J; Gilden DH
Arch Neurol; 2006 Jul; 63(7):940-2. PubMed ID: 16682531
[TBL] [Abstract][Full Text] [Related]
17. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
[TBL] [Abstract][Full Text] [Related]
18. Responsiveness of fibromyalgia clinical trial outcome measures.
Dunkl PR; Taylor AG; McConnell GG; Alfano AP; Conaway MR
J Rheumatol; 2000 Nov; 27(11):2683-91. PubMed ID: 11093454
[TBL] [Abstract][Full Text] [Related]
19. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.
Leone PA; Trottier S; Miller JM
Clin Infect Dis; 2002 Apr; 34(7):958-62. PubMed ID: 11880962
[TBL] [Abstract][Full Text] [Related]
20. Valacyclovir. New indication: for genital herpes, simpler administration.
Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
